# Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

> **NCT02048917** · PHASE1 · COMPLETED · sponsor: **University of Kentucky** · enrollment: 93 (actual)

## Conditions studied

- Lung Cancer
- Head and Neck Cancer

## Interventions

- **DRUG:** High Intensity Counseling + Long Acting NRT + PRN NRT
- **DRUG:** High Intensity Counseling + bupropion + PRN NRT
- **DRUG:** High Intensity Counseling + varenicline + PRN NRT
- **DRUG:** High Intensity Counseling + Long Acting NRT
- **DRUG:** High Intensity Counseling + bupropion
- **DRUG:** High Intensity Counseling + varenicline
- **DRUG:** Low Intensity Counseling + Long Acting NRT + PRN NRT
- **DRUG:** Low Intensity Counseling + bupropion + PRN NRT
- **DRUG:** Low Intensity Counseling + varenicline + PRN NRT
- **DRUG:** Low Intensity Counseling + Long Acting NRT
- **DRUG:** Low Intensity Counseling + bupropion
- **DRUG:** Low Intensity Counseling + varenicline

## Key facts

- **NCT ID:** NCT02048917
- **Lead sponsor:** University of Kentucky
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-22
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2020-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048917, "Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02048917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*